ATCC, CDC, Thermo Fisher Partner to Bring HIV Drug Resistance Assay to Resource-Poor Countries | GenomeWeb

NEW YORK (GenomeWeb) — ATCC has partnered with the US Centers for Disease Control and Prevention and Thermo Fisher Scientific to bring a rapid, cost-effective PCR-based method of monitoring HIV drug resistance to resource-limited countries, ATCC said today.

Specifically, ATCC and CDC have partnered to scale up and distribute the kit to World Health Organization-designated and CDC-supported genotyping laboratories established through the US President's Emergency Plan for AIDS Relief (PEPFAR).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.